21 September 2023 - From a regulator's point of view, a market authorisation can only be granted with a positive benefit-risk ...
22 March 2022 - Minjuvi is a new therapeutic option for eligible DLBCL patients in Switzerland addressing an urgent unmet medical ...
17 February 2022 - With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global ...
12 October 2021 - Seventh approval worldwide for Qinlock and first European approval. ...
24 August 2021 - Rubraca is commercially available in Germany, United Kingdom, Italy, Spain, France, Netherlands, United States of America and ...
18 August 2021 - BeiGene announced that Swissmedic has accepted the marketing authorisation application for Brukinsa, a treatment option for adult ...
20 July 2020 - The filing is based on the Phase II multi-centre basket trial efficacy data. ...
12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...
3 April 2018 - Roche said Tuesday that its prescription medicine Alecensa has been approved in Switzerland as a first-line ...
24 February 2016 - European regulators have approved Eli Lilly’s Portrazza as a treatment for patients with advanced non-small cell lung ...
4 September 2015 - Novartis announced today that the European Commission has approved Farydak (panobinostat, previously known as LBH589) capsules, in ...
1 September 2015 - Novartis today announced that the European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) ...